Critics of America’s current drug payment system say middlemen are jacking up prices and question why AARP, which is tied to a middleman organization, opposes a Trump administration proposal that could help seniors. Right now, these middleman organizations, called pharmacy benefit managers (PBMs), are protected by safe harbor provisions from certain parts of the Anti-Kickback Statute.
